文献速递儿童消化与营养儿童感染

巴基斯坦脱水儿童口服昂丹司琼的随机临床试验

Oral Ondansetron Administration to Dehydrated Children in Pakistan: A Randomized Clinical Trial.
PubMed 文献 · Pediatrics · 2019-11-06

在巴基斯坦2个儿科急诊科开展的随机双盲安慰剂对照优效试验纳入918例6-60月龄脱水儿童,口服昂丹司琼组72小时内静脉补液比例为14.7%,安慰剂组为19.5%(差异-4.8%,95%CI -9.7%至0.0%),昂丹司琼减少了呕吐和静脉补液使用。

要点

  • 口服昂丹司琼可减少脱水腹泻儿童呕吐,观察期呕吐率差异-12.9%。
  • 昂丹司琼组72小时内静脉补液比例14.7%,安慰剂组19.5%。
  • 昂丹司琼可能用于中低收入国家促进口服补液成功。

核心结论

  • 在伴呕吐和脱水的胃肠炎儿童中,口服昂丹司琼减少了呕吐和静脉补液使用。

研究设计与样本

  • 在巴基斯坦2个儿科急诊科开展随机双盲安慰剂对照优效试验,纳入918例6至60月龄脱水儿童。

主要发现

  • 昂丹司琼组72小时内静脉补液比例为14.7%(68/462),安慰剂组为19.5%(89/456),差异-4.8%(95%CI -9.7%至0.0%)。
  • 多变量logistic回归调整其他止吐药、抗生素、锌和前24小时呕吐次数后,昂丹司琼组主要结局比值比为0.70(95%CI 0.49至1.00)。
  • 昂丹司琼组观察期呕吐比例较安慰剂组低,差异-12.9%(95%CI -18.0%至-7.8%),呕吐次数中位数更低(P < .001)。

关键数值与推荐

  • 口服昂丹司琼单次剂量按体重:8-15 kg给2 mg,>15 kg给4 mg。
  • 主要结局为随机分组后72小时内4小时内静脉给予≥20 mL/kg等渗液体。
  • 入选条件为6至60月龄脱水儿童,前4小时内至少1次腹泻便和至少1次呕吐。

临床怎么用

  • 对于中低收入国家伴呕吐和脱水的胃肠炎儿童,可考虑使用口服昂丹司琼以促进口服补液治疗成功。

局限性

  • 研究在巴基斯坦2个儿科急诊科进行,外推至其他中低收入国家需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Ondansetron is an effective antiemetic employed to prevent vomiting in children with gastroenteritis in high-income countries; data from low- and middle-income countries are sparse. METHODS: We conducted a randomized, double-blind, placebo-controlled superiority trial in 2 pediatric emergency departments in Pakistan. Dehydrated children aged 6 to 60 months with ≥1 diarrheal (ie, loose or liquid) stool and ≥1 vomiting episode within the preceding 4 hours were eligible to participate. Participants received a single weight-based dose of oral ondansetron (8-15 kg: 2 mg; >15 kg: 4 mg) or identical placebo. The primary outcome was intravenous administration of ≥20 mL/kg over 4 hours of an isotonic fluid within 72 hours of random assignment. RESULTS: All 918 (100%) randomly assigned children completed follow-up. Intravenous rehydration was administered to 14.7% (68 of 462) and 19.5% (89 of 456) of those administered ondansetron and placebo, respectively (difference: -4.8%; 95% confidence interval [CI], -9.7% to 0.0%). In multivariable logistic regression analysis adjusted for other antiemetic agents, antibiotics, zinc, and the number of vomiting episodes in the preceding 24 hours, children administered ondansetron had lower odds of the primary outcome (odds ratio: 0.70; 95% CI, 0.49 to 1.00). Fewer children in the ondansetron, relative to the placebo group vomited during the observation period (difference: -12.9%; 95% CI, -18.0% to -7.8%). The median number of vomiting episodes (P < .001) was lower in the ondansetron group. CONCLUSIONS: Among children with gastroenteritis-associated vomiting and dehydration, oral ondansetron administration reduced vomiting and intravenous rehydration use. Ondansetron use may be considered to promote oral rehydration therapy success among dehydrated children in low- and middle-income countries.

来源:Pediatrics,查看原文。版权归原作者所有。

引用

  1. Freedman SB, Soofi SB, Willan AR, et al. Oral Ondansetron Administration to Dehydrated Children in Pakistan: A Randomized Clinical Trial. Pediatrics. 2019. PMID: 31694979. doi:10.1542/peds.2019-2161

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。